TY - JOUR
T1 - Lifetime risk of stroke stratified by chronic kidney disease and hypertension in the general Asian population
T2 - the Ohasama study
AU - Nakayama, Shingo
AU - Satoh, Michihiro
AU - Metoki, Hirohito
AU - Murakami, Takahisa
AU - Asayama, Kei
AU - Hara, Azusa
AU - Hirose, Takuo
AU - Kanno, Atsuhiro
AU - Inoue, Ryusuke
AU - Tsubota-Utsugi, Megumi
AU - Kikuya, Masahiro
AU - Mori, Takefumi
AU - Hozawa, Atsushi
AU - Imai, Yutaka
AU - Ohkubo, Takayoshi
N1 - Funding Information:
Funding This study was supported by Grants for Scientific Research (16H05243, 16H05263, 16K09472, 16K11850, 16K15359, 17H04126, 17H06533, 17K15853, 17K19930, 18K09674, 18K09904, 18K17396, 19K19466, 19H03908, 19K10662, and 20K08612) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for Young Scientists of Showa Pharmaceutical University H28-4; the Japan Arteriosclerosis Prevention Fund; Grant–in–aid from the Ministry of Health, Labor, and Welfare, Japan (H26-Junkankitou [Seisaku]-Ippan-001, H29–Junkankitou–Ippan–003 and 20FA1002); A Scheme to Revitalize Agriculture and Fisheries in Disaster Area through Deploying Highly Advanced Technology (NouEi 2-02) from the Ministry of Agriculture, Forestry and Fisheries, Japan; the internal research grants from Keio University; Advanced Comprehensive Research Grants of Teikyo University; the Academic Contributions from Pfizer Japan Inc.; scholarship donations from Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd.; research supports from Astellas Pharma Inc. and Takeda Pharmaceutical Co., Ltd.; the Health Care Science Institute Research Grant; and the Health Science Center Research Grant.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to The Japanese Society of Hypertension.
PY - 2021/7
Y1 - 2021/7
N2 - Lifetime risk (LTR) evaluates the absolute risk of developing a disease during the remainder of one’s life. It can be a useful tool, enabling the general public to easily understand their risk of stroke. No study has been performed to determine the LTR of cardiovascular disease in patients with chronic kidney disease (CKD) with or without hypertension; therefore, we performed this study in an Asian population. We followed 1525 participants (66.0% women; age 63.1 years) in the general population of Ohasama, Japan. We defined CKD as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 and/or proteinuria. Hypertension was defined as a systolic/diastolic blood pressure ≥140/≥90 mmHg and/or the use of antihypertensive medication. We calculated the sex-specific LTR of stroke adjusted for the competing risk of death. During the mean follow-up period of 16.5 years, a first stroke occurred in 238 participants. The 10-year risk of stroke at the age of 45 years was 0.0% for men and women. The LTRs of stroke at the index age of 45 years (men/women) were 20.9%/14.5% for participants without CKD and hypertension, 34.1%/29.8% for those with CKD but not hypertension, 37.9%/27.3% for those with hypertension but not CKD, and 38.4%/36.4% for those with CKD and hypertension. The LTRs of stroke tended to be higher in younger participants than in older participants with CKD and/or hypertension. CKD contributed to the LTR of stroke, as did hypertension. The prevention of CKD and hypertension can reduce the LTR of stroke, especially in young populations.
AB - Lifetime risk (LTR) evaluates the absolute risk of developing a disease during the remainder of one’s life. It can be a useful tool, enabling the general public to easily understand their risk of stroke. No study has been performed to determine the LTR of cardiovascular disease in patients with chronic kidney disease (CKD) with or without hypertension; therefore, we performed this study in an Asian population. We followed 1525 participants (66.0% women; age 63.1 years) in the general population of Ohasama, Japan. We defined CKD as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 and/or proteinuria. Hypertension was defined as a systolic/diastolic blood pressure ≥140/≥90 mmHg and/or the use of antihypertensive medication. We calculated the sex-specific LTR of stroke adjusted for the competing risk of death. During the mean follow-up period of 16.5 years, a first stroke occurred in 238 participants. The 10-year risk of stroke at the age of 45 years was 0.0% for men and women. The LTRs of stroke at the index age of 45 years (men/women) were 20.9%/14.5% for participants without CKD and hypertension, 34.1%/29.8% for those with CKD but not hypertension, 37.9%/27.3% for those with hypertension but not CKD, and 38.4%/36.4% for those with CKD and hypertension. The LTRs of stroke tended to be higher in younger participants than in older participants with CKD and/or hypertension. CKD contributed to the LTR of stroke, as did hypertension. The prevention of CKD and hypertension can reduce the LTR of stroke, especially in young populations.
KW - Lifetime risk
KW - chronic kidney disease
KW - epidemiology
KW - hypertension
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85102717252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102717252&partnerID=8YFLogxK
U2 - 10.1038/s41440-021-00635-z
DO - 10.1038/s41440-021-00635-z
M3 - Article
C2 - 33742168
AN - SCOPUS:85102717252
SN - 0916-9636
VL - 44
SP - 866
EP - 873
JO - Hypertension Research
JF - Hypertension Research
IS - 7
ER -